Finally, the NCDB does not include data on kidney function, body mass index, performance status, treatment-related toxic effects, response rates, progression-free survival, recurrence-free survival, PD-L1 status, or tumor mutational burden, all of which would have contributed to this analysis if available for study. This evidence concerns the gene CD274 and neoplasm.